Peter H. Lin

Peter Lin is an American vascular surgeon, medical researcher, specializing in minimally invasive endovascular treatment of vascular disease. He has published extensively in the area of vascular surgery and endovascular surgery.

For other people named Peter Lin, see Peter Lin (disambiguation).
Peter H. Lin
Dr. Peter H. Lin
Education
OccupationVascular surgeon
Medical career
InstitutionsBaylor College of Medicine
Websitewww.drpeterlin.com

Lin is Professor Emeritus of Surgery at the Baylor College of Medicine in Houston, Texas, where he was a member of its surgical faculty from 2001 to 2015. He also served as the Chief of Vascular Surgery at the Michael E. DeBakey Veterans Affairs Medical Center in Houston from 2001 to 2007. In 2006, he became Chief of Vascular Surgery of the Department of Surgery at Baylor College of Medicine, holding that position until 2015 when he moved to Los Angeles.[1][2]

Early life and education

Lin was born in Taiwan, and he earned his undergraduate degree in biology from the University of California, Riverside in 1988. He graduated from the Rosalind Franklin University of Medicine and Science / Chicago Medical School in Chicago Illinois in 1992. He completed his general surgery residency at Mount Sinai Medical Center in Chicago, Illinois, and was concurrently a research assistant in the Vascular Surgery Research Lab at the Loyola Stritch School of Medicine in Maywood, Illinois. From 1998 to 2000, he completed a Vascular Surgery fellowship and an Endovascular Surgery fellowship at the Emory University School of Medicine in Atlanta, Georgia.

Medical career

As a faculty member at Baylor, he carried out research in vascular surgery. His clinical interests primarily involve minimally invasive endovascular therapy of deep vein thrombosis, peripheral arterial disease, and pulmonary embolism. His clinical experience in endovascular intervention in part contributed to the clinical approval of treatment indication using thrombolytic therapy in acute pulmonary embolism.[3][4][5]

As Chief of Vascular Surgery at the Veterans Affairs Medical Center in Houston, Lin developed its vascular program into a premier clinical service in the VA healthcare system. The success of this vascular surgery program with veterans led to the visit of President George H.W. Bush in 2003.[6]

He served as a physician advisor to Congressman Gene Green who introduced Aneurysm Detection Bill in 2004 which provided Medicare coverage for Abdominal Aortic Aneurysm (AAA) screening and detection.[7] The legislation became known as the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act of 2004 (HR 4626).

Research interests and contributions

Lin has published more than 400 scholarly articles in scientific journals. He serves on the editorial boards or as a reviewer for many scientific journals. He has authored more than 60 book chapters and edited 3 vascular textbooks. His writing and speaking have focused on a range of subjects including endovascular treatment of aortic aneurysms, venous disease, endovascular treatment of lower extremity occlusive disease, experimental models of endovascular therapy, and thrombolysis in arterial and venous thrombosis research.

Lin's research interest is in cellular dysfunction in arterial and venous thrombosis as well as experimental model of endovascular therapy. His research expertise also includes clinical outcome of endovascular interventions. He was the principal investigator on a five-year National Institute of Health grant to study hypertension and homocysteinemia in atherosclerotic lesion formation.[8]

Honors and awards
  • 2001 - Allastair Karmody Award – Society for Clinical Vascular Surgery[1]
  • 2002 - American Venous Forum Research Award[1]
  • 2008 - Baylor College of Medicine Michael E. DeBakey Distinguished Service Award[1]

Publications

Partial list:

  • Lin, P.H. (2011). "Endovascular interventions for acute pulmonary embolism". Perspectives in Vascular Surgery and Endovascular Therapy. 22 (3): 171–182. doi:10.1177/1531003510379880. PMID 21098498.
  • Lin, P.H. (2010). "Catheter-directed thrombectomy and thrombolysis for symptomatic lower-extremity deep vein thrombosis". Perspectives in Vascular Surgery and Endovascular Therapy. 22 (3): 152–163. doi:10.1177/1531003510378756. PMID 21098496.
  • Lin, P.H.; Weakley, S.M.; Kougias, P. (2010). "How to interpret data from the superficial femoral artery stenting trials and registries". Seminar of Vascular Surgery. 23 (3): 138–147. doi:10.1053/J.SEMVASCSURG.2010.05.001. PMID 20826290.
  • Lin, P.H. (2009). "Comparison of percutaneous ultrasound accelerated thrombolysis vesus catheter-directed thrombolysis in patients with acute massive pulmonary embolism". Vascular. 18 (1): 63–68. doi:10.2310/6670.2009.00063. PMID 19919804. S2CID 4828023.
  • Lin, P.H. (2009). "Hypogastric artery preservation during endovascular aortic aneurysm repair: is it important?". Seminar of Vascular Surgery. 22 (3): 193–200. doi:10.1053/j.semvascsurg.2009.07.012. PMID 19765531.
  • Lin, P.H. (2008). "Endovascular repair of traumatic thoracic aortic injuries: a critical appraisal". Asian Cardiovasc Thorac Ann. 16 (4): 337–345. doi:10.1177/021849230801600419. PMID 18670033. S2CID 4842622.
  • Lin, P.H. (2009). "Descending thoracic aortic dissection: evaluation and management in the era of endovascular technology". Vascular and Endovascular Surgery. 43 (1): 5–24. doi:10.1177/1538574408318475. PMID 18583304. S2CID 4826109.
  • Lin, P.H. (2008). "Concomitant colorectal cancer and abdominal aortic aneurysm: evolution of treatment paradigm in the endovascular era". Journal of the American College of Surgeons. 206 (5): 1065–1073. doi:10.1016/j.jamcollsurg.2007.12.011. PMID 18471757.
  • Lin, P.H. (2008). "Prospective randomized trials of carotid artery stenting versus carotid endarterectomy: an appraisal of the current literature". Vascular and Endovascular Surgery. 42 (1): 5–11. doi:10.1177/1538574407312654. PMID 18238861. S2CID 4800233.

References
  1. "UVA University Vascular Associates". universityvascular.com.
  2. "Peter Lin, MD Vascular Surgery Los Angeles, Ca". Peter Lin, MD. Archived from the original on 2016-03-04. Retrieved 2015-09-08.
  3. "EKOS Corporation Receives CE Mark to Treat Massive and Sub-Massive Pulmonary Embolism | Business Wire". www.businesswire.com. 17 January 2011. Retrieved 2012-09-08.
  4. "EKOS Receives Approval to Treat Massive and Sub-Massive Pulmonary Embolism". Reuters. 2011-01-17. Retrieved 2015-09-08.
  5. "New Treatment Is Saving the Lives of Patients Suffering from a Pulmonary Embolism". veins1.com. Retrieved 2013-05-08.
  6. Center, US Department of Veterans Affairs, Veterans Health Administration, Deputy Under Secretary for Operations and Management, Veterans Integrated Services Network 16, Houston VA Medical. "President George H. W. Bush Visits Houston VA Medical Center - Michael E. DeBakey VA Medical Center - Houston, Texas". www.houston.va.gov. Retrieved 2005-05-07.{{cite web}}: CS1 maint: multiple names: authors list (link)
  7. "Green Introduces Aneurysm Detection Bill". Retrieved 2008-03-08.
  8. labome.org. "Homocysteine/Hypertension & Vascular Lesion Formation". www.labome.org. Retrieved 2008-03-09.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.